Warfarin Sodium
- Product NDC
- 70518-2383
- Requested package NDC
- 70518-2383-0
- 11-digit product format
- 705182383
- Labeler code
- 70518
- Product ID
- 70518-2383_4a152b72-65fd-e48b-e063-6394a90a1b84
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Warfarin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA202202
- Marketing category
- ANDA
- Marketing start
- 2019-10-24
- Substance
- WARFARIN SODIUM
- Active strength
- 1 mg/1
- Pharmacologic classes
- Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A202202-001 | WARFARIN SODIUM | WARFARIN SODIUM | 1MG | TABLET / ORAL | AB | 2013-03-04 | |
| A202202-002 | WARFARIN SODIUM | WARFARIN SODIUM | 2MG | TABLET / ORAL | AB | 2013-03-04 | |
| A202202-003 | WARFARIN SODIUM | WARFARIN SODIUM | 2.5MG | TABLET / ORAL | AB | 2013-03-04 | |
| A202202-004 | WARFARIN SODIUM | WARFARIN SODIUM | 3MG | TABLET / ORAL | AB | 2013-03-04 | |
| A202202-005 | WARFARIN SODIUM | WARFARIN SODIUM | 4MG | TABLET / ORAL | AB | 2013-03-04 | |
| A202202-006 | WARFARIN SODIUM | WARFARIN SODIUM | 5MG | TABLET / ORAL | AB | 2013-03-04 | |
| A202202-007 | WARFARIN SODIUM | WARFARIN SODIUM | 6MG | TABLET / ORAL | AB | 2013-03-04 | |
| A202202-008 | WARFARIN SODIUM | WARFARIN SODIUM | 7.5MG | TABLET / ORAL | AB | 2013-03-04 | |
| A202202-009 | WARFARIN SODIUM | WARFARIN SODIUM | 10MG | TABLET / ORAL | AB | 2013-03-04 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A202202-001 | AB |
| A202202-002 | AB |
| A202202-003 | AB |
| A202202-004 | AB |
| A202202-005 | AB |
| A202202-006 | AB |
| A202202-007 | AB |
| A202202-008 | AB |
| A202202-009 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A202202-001 | WARFARIN SODIUM | 1MG | TABLET / ORAL | AB | 2013-03-04 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A202202-002 | WARFARIN SODIUM | 2MG | TABLET / ORAL | AB | 2013-03-04 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A202202-003 | WARFARIN SODIUM | 2.5MG | TABLET / ORAL | AB | 2013-03-04 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A202202-004 | WARFARIN SODIUM | 3MG | TABLET / ORAL | AB | 2013-03-04 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A202202-005 | WARFARIN SODIUM | 4MG | TABLET / ORAL | AB | 2013-03-04 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A202202-006 | WARFARIN SODIUM | 5MG | TABLET / ORAL | AB | 2013-03-04 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A202202-007 | WARFARIN SODIUM | 6MG | TABLET / ORAL | AB | 2013-03-04 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A202202-008 | WARFARIN SODIUM | 7.5MG | TABLET / ORAL | AB | 2013-03-04 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A202202-009 | WARFARIN SODIUM | 10MG | TABLET / ORAL | AB | 2013-03-04 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A202202-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A202202-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A202202-003 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A202202-004 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A202202-005 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A202202-006 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A202202-007 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A202202-008 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A202202-009 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Warfarin Sodium | WARFARIN | A-S Medication Solutions | 541c9a70-adaf-4ef3-94ba-ad4e70dfa057 | 2026-07-23 | Boxed warning, Warnings, Adverse reactions | 202202 ANDA202202 |
| Warfarin Sodium | WARFARIN | REMEDYREPACK INC. | d7fb4290-ed37-4ed3-ae51-c400191961dc | 2026-06-30 | Boxed warning, Warnings, Adverse reactions | 202202 ANDA202202 |
| Warfarin Sodium | WARFARIN | REMEDYREPACK INC. | 51e98fb6-ba76-497e-95d8-fe895ef0b7ed | 2026-06-29 | Boxed warning, Warnings, Adverse reactions | 202202 ANDA202202 |
| Warfarin Sodium | WARFARIN | REMEDYREPACK INC. | a4cf3107-5646-4b91-8aae-94548e4409ef | 2026-06-29 | Boxed warning, Warnings, Adverse reactions | 202202 ANDA202202 70518-2383-0 70518-2383 70518238300 |
| Warfarin Sodium | WARFARIN | REMEDYREPACK INC. | 2fb8b8d5-f643-4069-8e47-5eae31a8fbc8 | 2026-06-29 | Boxed warning, Warnings, Adverse reactions | 202202 ANDA202202 |
| Warfarin Sodium | WARFARIN | REMEDYREPACK INC. | 884cdbf6-0a52-4126-8e14-b0d7c9367e33 | 2026-06-29 | Boxed warning, Warnings, Adverse reactions | 202202 ANDA202202 |
| Warfarin Sodium | WARFARIN | REMEDYREPACK INC. | 8eddba53-19c4-411b-b0d4-cb2f948ba125 | 2026-06-29 | Boxed warning, Warnings, Adverse reactions | 202202 ANDA202202 |
| Warfarin Sodium | WARFARIN | REMEDYREPACK INC. | 2cbcc99d-9107-4d39-a1e9-e19305de8b5d | 2026-06-25 | Boxed warning, Warnings, Adverse reactions | 202202 ANDA202202 |
| Warfarin Sodium | WARFARIN | REMEDYREPACK INC. | 8ee94789-72d2-4c42-9dbd-0501e9767d97 | 2026-06-25 | Boxed warning, Warnings, Adverse reactions | 202202 ANDA202202 |
| Warfarin Sodium | WARFARIN | REMEDYREPACK INC. | 545ec40d-2db1-4581-b3ec-ce195e5f5400 | 2026-06-25 | Boxed warning, Warnings, Adverse reactions | 202202 ANDA202202 |
| Warfarin Sodium | WARFARIN | Amneal Pharmaceuticals LLC | 558b7a0d-5490-4c1b-802e-3ab3f1efe760 | 2026-05-29 | Boxed warning, Warnings, Adverse reactions | 202202 ANDA202202 |
| Warfarin Sodium | WARFARIN | Coupler LLC | 52bacf1e-9ba8-7eca-e063-6394a90ab60b | 2026-05-26 | Boxed warning, Warnings, Adverse reactions | 202202 ANDA202202 |
| Warfarin Sodium | WARFARIN | Coupler LLC | 5256c518-31bf-f73b-e063-6394a90a71da | 2026-05-21 | Boxed warning, Warnings, Adverse reactions | 202202 ANDA202202 |
| Warfarin Sodium | WARFARIN | Coupler LLC | 2f2119e8-f583-ba16-e063-6394a90a13a2 | 2025-02-27 | Boxed warning, Warnings, Adverse reactions | 202202 ANDA202202 |
| Warfarin Sodium | WARFARIN | Coupler LLC | 2d58d204-4976-95cf-e063-6394a90a34b7 | 2025-02-04 | Boxed warning, Warnings, Adverse reactions | 202202 ANDA202202 |
| Warfarin Sodium | WARFARIN | Bryant Ranch Prepack | 8c876dd3-d659-479e-994c-39454c7028cc | 2025-01-28 | Boxed warning, Warnings, Adverse reactions | 202202 ANDA202202 |
| WARFARIN SODIUM | WARFARIN SODIUM | Direct_Rx | efded00a-22b9-1da7-e053-2995a90a58ca | 2025-01-22 | Boxed warning, Warnings, Adverse reactions | 202202 ANDA202202 |
| Warfarin Sodium | WARFARIN | Preferred Pharmaceuticals Inc. | ac117f50-8e67-4203-8d97-e53dd0687c20 | 2025-01-17 | Boxed warning, Warnings, Adverse reactions | 202202 ANDA202202 |
| Warfarin Sodium | WARFARIN | Bryant Ranch Prepack | 7fdfd870-e72d-4d88-b6d9-1d711b66d09f | 2024-01-02 | Boxed warning, Warnings, Adverse reactions | 202202 ANDA202202 |
| Warfarin Sodium | WARFARIN | Bryant Ranch Prepack | 3dd9f8ce-75e0-426a-9d22-6af7742a0ca7 | 2023-12-14 | Boxed warning, Warnings, Adverse reactions | 202202 ANDA202202 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Warfarin Sodium
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| WARFARIN SODIUM | 1 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 6153CWM0CL | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 855288 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| a4cf3107-5646-4b91-8aae-94548e4409ef | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| abcfe2f4-1eca-fdc3-341b-b8134a1aec1f | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-2383-0 | Warfarin Sodium | 100 in 1 BOX | TABLET | 100 | 10 | |
| 70518-2383-1 | Warfarin Sodium | 1 in 1 POUCH | TABLET | 1 | 10 | |
| 70518-2383-2 | Warfarin Sodium | 30 in 1 BOTTLE, PLASTIC | TABLET | 30 | 10 | |
| 70518-2383-3 | Warfarin Sodium | 30 in 1 BLISTER PACK | TABLET | 30 | 10 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 855288 | warfarin sodium 1 MG Oral Tablet | PSN | a4cf3107-5646-4b91-8aae-94548e4409ef | 10 |
| 855288 | warfarin sodium 1 MG Oral Tablet | SCD | a4cf3107-5646-4b91-8aae-94548e4409ef | 10 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 70518-2383-0 | 70518238300 | 100 POUCH in 1 BOX (70518-2383-0) / 1 TABLET in 1 POUCH (70518-2383-1) | 100 pouch | 2019-10-24 | 0000-00-00 | No | No | Current |